KCT0004995
Not yet recruiting
未知
The evaluation of safety and efficacy of OptimosTM s sphincterotome in patient with biliary disease requiring endoscopic retrograde cholangiopancreatography : A multicenter prospective cohort study
Yonsei University Health System, Gangnam Severance Hospital0 sites200 target enrollmentTBD
ConditionsDiseases of the digestive system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the digestive system
- Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Enrollment
- 200
- Status
- Not yet recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with original biliary papilla
- •2\. Patients with or suspected of having biliary tract disease
- •3\. Patients in need of endoscopic retrograde cholangiopancreatography for treatment
Exclusion Criteria
- •1\.Under 19
- •2\.Pregnant patients
- •3\. Patients with reduced intelligence
- •4\. Patients sensitive to contrast agents
- •5\.Patients who had previously undergone papillary incision
- •6\.Biliary papillary tumor patients
- •7\.Patients who underwent hepatobiliary surgery
- •8\.Patients who have difficulty endoscopically accessing the biliary papilla due to abdominal surgery (eg, gastrectomy, total gastrectomy)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the safety and efficacy of the Optimizer™ II and III systems with active fixation leads in subjects with heart failure resulting from systolic dysfunctioHeart failureCirculatory SystemISRCTN16213127Impulse Dynamics Inc. (USA)250
Active, not recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.HypertensionMedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-004891-16-LVInstitut de Recherches Internationales Servier968
Recruiting
Not Applicable
Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation deviceBronchial AsthmaJPRN-UMIN000015602Kinki university Department of respiratory medicine and allergology50
Active, not recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.HypertensionMedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-004891-16-CZInstitut de Recherches Internationales Servier968
Active, not recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.HypertensionMedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-004891-16-PLInstitut de Recherches Internationales Servier968